愛媛県立中央病院は、愛媛県が病院事業として設置・運営している病院の一つ。中予地区の拠点医療機関として、高度救命救急センター、総合周産期母子医療センターなども設置されている。PFIの導入による建て替えが行われ、2014年12月1日に完了した。 略称は「県中」、または「県病院」。

During the past decade, Ehime Prefectural Central Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ehime Prefectural Central Hospital" are "Carcinoma, Hepatocellular" (1 trials), "Central Neuropathic Pain" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Ehime Prefectural Central Hospital" in a lesser frequency.

Most popular intervention types in "Ehime Prefectural Central Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Guselkumab" (1 trials) and "Mirogabalin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ehime Prefectural Central Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ehime Prefectural Central Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ehime Prefectural Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ehime Prefectural Central Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".